First-line anti-PD1/PD-L1-based therapy for patients with advanced squamous NSCLC: a systematic review and meta-analysis

Thiago Madeira; Maysa Vilbert; Isabella Michelon; Jonathan Priantti; Maria Inez Dacoregio; Vladmir Lima

doi:10.1055/s-0045-1808009

Brazilian Journal of Oncology, Table of Contents

CC BY 4.0 · Brazilian Journal of Oncology 2025; 21
DOI: 10.1055/s-0045-1808009

THORACIC TUMORS

1964

POSTER PRESENTATION

First-line anti-PD1/PD-L1-based therapy for patients with advanced squamous NSCLC: a systematic review and meta-analysis

Authors

Thiago Madeira
Maysa Vilbert
Isabella Michelon
Jonathan Priantti
Maria Inez Dacoregio
Vladmir Lima

Abstract

All articles of this category

Keywords

squamous NSCLC - immunotherapy - first-line - anti-PD1 - meta-analysis

Bibliographical Record
Thiago Madeira, Maysa Vilbert, Isabella Michelon, Jonathan Priantti, Maria Inez Dacoregio, Vladmir Lima. First-line anti-PD1/PD-L1-based therapy for patients with advanced squamous NSCLC: a systematic review and meta-analysis. Brazilian Journal of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808009

Full Text